ATE492630T1 - Primäre kultivierte adipozyten zur gentherapie - Google Patents

Primäre kultivierte adipozyten zur gentherapie

Info

Publication number
ATE492630T1
ATE492630T1 AT03736235T AT03736235T ATE492630T1 AT E492630 T1 ATE492630 T1 AT E492630T1 AT 03736235 T AT03736235 T AT 03736235T AT 03736235 T AT03736235 T AT 03736235T AT E492630 T1 ATE492630 T1 AT E492630T1
Authority
AT
Austria
Prior art keywords
gene therapy
adipocytes
cells
present
primary cultured
Prior art date
Application number
AT03736235T
Other languages
English (en)
Inventor
Masashi Ito
Yasushi Saito
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE492630T1 publication Critical patent/ATE492630T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03736235T 2002-06-18 2003-06-18 Primäre kultivierte adipozyten zur gentherapie ATE492630T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002177648 2002-06-18
JP2002237974 2002-08-19
PCT/JP2003/007721 WO2003106663A1 (ja) 2002-06-18 2003-06-18 遺伝子治療用初代培養脂肪細胞

Publications (1)

Publication Number Publication Date
ATE492630T1 true ATE492630T1 (de) 2011-01-15

Family

ID=29738440

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03736235T ATE492630T1 (de) 2002-06-18 2003-06-18 Primäre kultivierte adipozyten zur gentherapie

Country Status (20)

Country Link
US (2) US7820438B2 (de)
EP (2) EP2213730B1 (de)
JP (1) JPWO2003106663A1 (de)
KR (1) KR101004086B1 (de)
CN (1) CN1671836B (de)
AT (1) ATE492630T1 (de)
AU (1) AU2003242459B2 (de)
BR (1) BRPI0312441B8 (de)
CA (1) CA2488414C (de)
DE (1) DE60335473D1 (de)
DK (2) DK1541674T3 (de)
ES (1) ES2559430T3 (de)
HU (1) HUE025872T2 (de)
MA (1) MA27324A1 (de)
MX (1) MXPA04012859A (de)
NZ (1) NZ537072A (de)
PT (2) PT2213730E (de)
SI (1) SI1541674T1 (de)
WO (1) WO2003106663A1 (de)
ZA (1) ZA200500464B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4879867B2 (ja) * 2002-06-18 2012-02-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 遺伝子治療用初代培養脂肪細胞
EP1892294A4 (de) * 2005-06-15 2010-04-14 Takara Bio Inc Verfahren zum transfer von genen in fettzellen oder vorläuferfettzellen
JPWO2008108344A1 (ja) * 2007-03-02 2010-06-17 セルジェンテック株式会社 Ｌｃａｔ欠損症の遺伝子治療用細胞並びに遺伝子治療用細胞組成物
TW200927074A (en) * 2007-12-25 2009-07-01 Univ Nat Taiwan Colloidal frame used in tissue engineering
JP2009165403A (ja) * 2008-01-16 2009-07-30 Hokkaido Univ ハニカム状多孔質体を用いた脂肪細胞の長期培養方法
WO2010047793A2 (en) * 2008-10-21 2010-04-29 The General Hospital Corporation Cell transplantation
WO2011090091A1 (ja) * 2010-01-21 2011-07-28 セルジェンテック株式会社 遺伝子治療用脂肪細胞の調製のための外来遺伝子の導入に適した細胞集団かどうかを判定する方法
KR101809301B1 (ko) 2010-08-06 2018-01-18 더 제너럴 하스피털 코포레이션 두잉 비즈니스 애즈 매사츄세츠 제너럴 하스피털 세포 처리 시스템 및 장치
KR20140009459A (ko) * 2011-03-16 2014-01-22 가부시키가이샤 구라레 배양 방법, 성숙 지방 세포군 및 약물 스크리닝 방법
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
JP7411180B2 (ja) 2020-05-29 2024-01-11 株式会社Numt Ｆｆａｒ４を高発現させた脂肪細胞及びその使用
EP4213863A1 (de) * 2020-09-15 2023-07-26 The Brigham and Women's Hospital, Inc. In-vivo-fettbioreaktor und kits zur herstellung und abgabe von biologischen mitteln
WO2023249904A1 (en) * 2022-06-20 2023-12-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating diabetes

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956455A (en) 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
ATE105868T1 (de) 1985-09-12 1994-06-15 Scios Nova Inc Rekombinanter fibroblast-wachstumsfaktor.
ATE107315T1 (de) 1985-12-17 1994-07-15 Synergen Inc Menschlicher plazentarer angiogenischer faktor, geeignet für die reizung der kapillarsynthese, der endothelzellprotease, der dns-synthese und der absiedlung.
IL81839A0 (en) 1986-03-14 1987-10-20 Takeda Chemical Industries Ltd Polypeptide,dna and its use
JP2526965B2 (ja) 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
JPH02504468A (ja) 1987-11-24 1990-12-20 アムジエン・インコーポレーテツド 繊維芽細胞成長因子のアナログ
EP0326907A1 (de) 1988-01-26 1989-08-09 Takeda Chemical Industries, Ltd. Polypeptide, DNA und ihre Verwendung
CA2015313A1 (en) 1989-04-26 1990-10-26 Masaharu Senoo Glycosylated fgf and production thereof
JP3135138B2 (ja) 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
EP0802800B1 (de) * 1993-08-12 2002-06-12 Neurotech S.A. Biokompatible immunoisolatorische Kapseln, die genetisch veränderte Zellen enthalten
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
FR2731710B1 (fr) 1995-03-14 1997-04-30 Rhone Poulenc Rorer Sa Virus recombinants exprimant la lecithine cholesterol acyltransferase et utilisations en therapie genique
US5869037A (en) * 1996-06-26 1999-02-09 Cornell Research Foundation, Inc. Adenoviral-mediated gene transfer to adipocytes
GB2327224A (en) 1997-07-09 1999-01-20 Mayo Foundation Gene transfer to adipocytes
WO1999011786A1 (fr) 1997-09-01 1999-03-11 Otsuka Pharmaceutical Co., Ltd. GENE pancpin ET COMPOSITION DE THERAPIE GENIQUE
WO1999023216A2 (en) 1997-11-03 1999-05-14 The Arizona Board Of Regents On Behalf Of The University Of Arizona Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
US6797505B2 (en) 1998-05-27 2004-09-28 Cell Genesys, Inc. Recombinant AAV vectors for gene therapy of hemophilia A
WO2000031267A1 (en) * 1998-11-20 2000-06-02 The Autonomous University Of Barcelona Insulin production by engineered muscle cells
US6153432A (en) * 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
CA2852534A1 (en) 1999-08-05 2001-02-15 Abt Holding Company Multipotent adult stem cells and methods for isolation
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US20020177551A1 (en) * 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
AU2001277539A1 (en) * 2000-07-18 2002-01-30 Societe Des Produits Nestle S.A. Pre-adipose cell lines
WO2003031640A2 (en) * 2001-10-06 2003-04-17 Boston Medical Center Corporation Preadipocyte cell strains and uses therefore
WO2003084468A2 (en) * 2002-04-03 2003-10-16 Artecel Sciences, Inc. Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof
JPWO2008108344A1 (ja) 2007-03-02 2010-06-17 セルジェンテック株式会社 Ｌｃａｔ欠損症の遺伝子治療用細胞並びに遺伝子治療用細胞組成物

Also Published As

Publication number Publication date
MXPA04012859A (es) 2005-03-31
DK2213730T3 (en) 2016-01-25
DK1541674T3 (da) 2011-03-14
BRPI0312441B1 (pt) 2018-03-20
MA27324A1 (fr) 2005-05-02
PT1541674E (pt) 2011-03-21
CA2488414A1 (en) 2003-12-24
WO2003106663A1 (ja) 2003-12-24
US7820438B2 (en) 2010-10-26
EP1541674A4 (de) 2007-01-10
EP1541674B1 (de) 2010-12-22
CA2488414C (en) 2011-04-26
BRPI0312441B8 (pt) 2021-05-25
CN1671836A (zh) 2005-09-21
SI1541674T1 (sl) 2011-04-29
KR101004086B1 (ko) 2010-12-27
KR20070087062A (ko) 2007-08-27
EP2213730A8 (de) 2010-11-10
AU2003242459B2 (en) 2007-05-17
ZA200500464B (en) 2005-12-28
NZ537072A (en) 2006-12-22
CN1671836B (zh) 2012-02-08
JPWO2003106663A1 (ja) 2005-10-13
EP2213730A1 (de) 2010-08-04
EP1541674A1 (de) 2005-06-15
ES2559430T3 (es) 2016-02-12
PT2213730E (pt) 2016-02-26
AU2003242459A1 (en) 2003-12-31
HUE025872T2 (en) 2016-05-30
US20090010901A1 (en) 2009-01-08
BR0312441A (pt) 2005-04-19
US20060121008A1 (en) 2006-06-08
DE60335473D1 (de) 2011-02-03
EP1541674B9 (de) 2011-09-14
EP2213730B1 (de) 2015-12-02
US8071085B2 (en) 2011-12-06

Similar Documents

Publication Publication Date Title
MA27324A1 (fr) Adipocytes de culture primaire utilises en therapie genique.
Smith et al. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment
US20060239980A1 (en) Cartilage-derived stem cells and applications thereof
PT1062321E (pt) Utilizacoes para celulas estaminais mesenquimais humanas nao autologas
EP1712616A4 (de) Induktion einer myokardzelle unter verwendung einer säuger-knochenmarkzelle oder aus nabelschnurblut stammenden zelle und fettgewebe
MXPA04004396A (es) Metodos y composiciones para correccion de perturbaciones de conduccion cardiaca.
EP2302034A3 (de) Verbesserte Verfahren zur Neuprogrammierung von sommatischen Tierzellen
ATE313634T1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
DE60225310D1 (de) Differenzierung vom gesamten knochenmark
ATE296875T1 (de) Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen
HUP0401945A2 (hu) Zsírszövetből származó stromasejtek, és azok alkalmazása a szaruhártya hibáinak és szemen belüli fogyatékosságok javítására
ES2325715A1 (es) Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
DK1274464T3 (da) Sammensætninger og fremgangsmåder til regulering af proteinekspression i tarm
Deans et al. Stem cells in musculoskeletal engineered tissue
DE60234163D1 (de) Zusammensetzungen zur gentherapie rheumatoider arthritis, die ein gen, das für ein anti-angiogenes protein oder teile davon kodiert, enthalten
WO2003059932A3 (en) Methods of inducing or enhancing connective tissue repair
ES2194794T3 (es) Dendrimeros fosforados como agentes de transfeccion.
MXPA02002444A (es) Metodo para generar celulas y tejidos inmunocompatibles, utilizando tecnicas de transferencia nuclear.
WO2002089726A3 (en) Method of making a homogeneous preparation of hematopoietic stem cells
CN103255101A (zh) 一种成釉细胞的分离培养方法
RS104404A (en) Control sequences of the human corin gene
DE50009932D1 (de) Gentransfer in humane lymphocyten mittels retroviraler scfv-zelltargeting vektoren
NO20050248L (no) Primaere, dyrkede adipocytter for genterapi
DE69916829D1 (de) Genetisch veränderte fibroblasten und ihre verwendung
WO2007031574A3 (en) Therapeutic use of outer shigella protein f (os pf)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1541674

Country of ref document: EP